Akebia Therapeutics, Inc. To Participate In Upcoming Investor Conferences

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced that John P. Butler, President and Chief Executive Officer, will participate in two upcoming investor conferences:

Help employers find you! Check out all the jobs and post your resume.

Back to news